share_log

Eledon Pharma Q4 2023 GAAP EPS $(0.32) Beats $(0.39) Estimate

Moomoo 24/7 ·  Mar 28 16:07

Eledon Pharma (NASDAQ:ELDN) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.39) by 17.95 percent.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment